Latest Publications

The aims of BRONCH-UK are to promote high quality research into bronchiectasis:

  1. To support intervention clinical trials aiming to better treatments
  2. Improve our understanding of the microbiology and infections in bronchiectasis
  3. To develop a biobank of samples that will lead to genetic studies to explain why patients get bronchiectasis.
  4. To understand abnormalities of the immune system in bronchiectasis 
  5. Increasing knowledge,  improving patient care

This page contains a list of studies and publications from the BRONCH-UK collaborators:


A 2 × 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults with bronchiectasis: a protocol for the CLEAR clinical trial

J M Bradley, R Anand, B O'Neill, K Ferguson, M Clarke, M Carroll, J Chalmers, A De Soyza, J Duckers, A T Hill, M R Loebinger, F Copeland, CLEAR study group... et al (see below) / Trials. 2019 Dec 19;20(1):747. Dec 19;20(1):747. doi: 10.1186/s13063-019-3766-9.